defined that intestinal epithelium is the major site of glucuronidation, but not sulfation 2 and methylation, of quercetin. 3
Introduction 32
Quercetin is one of the most abundant flavonol-type flavonoids found in nature. It 33 has been reported that quercetin has numerous physiological properties, such as antioxidant 34 [1] , anticancer [2] and antiarteriosclerotic activity [3] . However, an extent of their bioactivity 35 in vivo will be dependent on the amount of quercetin absorbed and metabolized. 36
Quercetin is present in the form of its glucoside derivatives, such as quercetin-4′-O-37 glucoside and quercetin-3-O-glucoside, in tea, onions, and apples [4] [5] [6] . Ingested quercetin 38 glucosides are hydrolyzed to quercetin aglycone in the small intestine [7] by the lactase 39 phlorizin hydrolase (LPH) enzyme. [8, 9] Absorbed quercetin aglycone is then converted to 40 glucuronidated, sulfated, and methylated quercetin derivatives by phase II metabolizing 41 enzymes such as UDP-glucuronosyl transferases (UGT), phenol sulfotransferases (SULT), 42 and catechol-O-methyltransferases (COMT), in liver and intestine [10] [11] . In systemic 43 circulation, quercetin metabolites exist mainly in the conjugated forms, but not as aglycone 44 [11] . Quercetin entered into the cecum and colon is degraded to phenolic acid derivatives, 45 such as 3-hydroxyphenylacetic acid and 3, 4-dihydroxyphenylacetic acid, by colonic 46 microflora [12] . 47 chemical structure of quercetin aglycone and its carbon numbers. All hydroxy group of 57 quercetin (3,5,7,3′ and 4') are conjugated with glucuronic acid or sulfonic acid. Only 3'-and 58 4′-hydroxy group in B ring of quercetin are acceptable for methylation. 59
Although a number of studies on absorption and metabolism of quercetin have been 60 conducted, only a few of them were conducted in physiological conditions. In our previous 61 study, we observed the quercetin absorption in ligated small intestinal loop of anesthetized 62 rats [15] , in which the intestinal ability to conjugate and methylate quercetin was possibly 63 either impaired or enhanced. The present study was designed to observe the intestinal ability 64 to form quercetin conjugates in conscious rats. We implanted cannulae into the portal vein 65 and the superior vena cava, and collected blood samples from both of them simultaneously 66 after an administration of quercetin glucosides in unrestrained conscious rats. The differences 67 in quercetin metabolite concentrations between the portal vein blood and the superior vena 68 cava blood (porto-venous differences) indicate absorption and metabolism (conjugation and 69 methylation) of quercetin in intestine. We assumed that the concentrations of quercetin 70 derivatives are almost the same between the blood in superior vena cava and that in the 71 arteries. Our previous study has reported the methods of collecting blood from superior vena 72 cava and portal vein to examine intestinal absorption [16] . We administered a water-soluble 73 quercetin glucoside through a feeding tube. 74
The objectives of this study are (i) to evaluate the contribution of the intestine in 75 formation of quercetin glucuronides and sulfates, and (ii) to examine regioselectivity in 76 glucuronidation and sulfation of quercetin after an oral administration of a quercetin 77 glycoside in conscious rats.
Materials 80
A mixture of water-soluble quercetin glucosides (Q3GM) is mainly composed of 81 quercetin-3-O-glucoside (Q3G, 31.8%), mono-(23.3%), and di-(20.3%) glucose adducts on 82 the glucose moiety of Q3G with α-1, 4-linkages (San-Ei Gen F.F.I, Inc., Osaka, Japan), 83 which is enzymatically produced with transglycosylation [17] . The mixture also includes tri-84 to hepta-adducts as minor components. Standard preparations of quercetin and tamarixetin 85 (methylquercetin) were purchased from Extrasynthese (Genay, France Somnopentyl Injection; Kyoritsu Seiyaku Co, Tokyo, Japan). The right jugular vein was 104 exposed, and a silicone tube (Silascon No. 00, ID 0.5 mm, OD 1.0 mm; Kaneka, Osaka, 105 Japan) was inserted 5 cm into the blood vessel and fixed with a thread. The tip of the catheter 106 reached the superior vena cava. An abdominal midline incision was made on rats, and the 107 small tip (5-6 mm) of a polyethylene tube (SP28; ID 0.4 mm, OD 0.8 mm; Natsume 108 Seisakusyo, Tokyo, Japan) connected to a silicone tube was inserted into the portal vein and 109 fixed with instant adhesive. Both catheters were prefilled with sterilized saline that contained 110 heparin (200 IU/mL; AY pharmaceuticals, Tokyo, Japan). Free ends of the catheters were 111 dorsally exteriorized, which permitted us to conduct the experiment on the rats under awake 112 and unrestrained conditions. The rats were then used for experiments after a recovery period 113 for 2 days. To prevent blood coagulation, the jugular and portal catheters were flushed with 114 heparinized saline every day. 115
Absorption of quercetin glycosides in conscious rats 116
We examined the quercetin absorption in conscious rats after an oral administration 117 of a water-soluble quercetin glucoside mixture (Q3GM) through a feeding tube (5 mL/kg BW, 118 Q3GM 100 mmol/L in deionized water) after 16 h of fasting. Blood samples (150 μL) were 119 drawn through the jugular and portal catheters before (i.e., at 0 min), and at 30, 60, 120, 180, 120 and 240 min after an oral gavage. Blood was centrifuged (4 °C, 10 min, 2300 g), and the 121 plasma was collected and stored at -80 °C until further analyses. 122
Sample Preparation for LC/MS/MS analyses. 124
Preparation of plasma samples was performed similar to a previously described 125 method with minor modifications [15] . The plasma (20 μL) from the portal blood was added 126 to a mixture of 80 μL of deionized water and 10 μL of 0.58 mol/L acetic acid (pH 4.9). The 127
final mixture was then added to 100 μL of methanol containing an internal standard 128 (naringenin, final 2 μmol/L), heated at 100 °C for 1 min, and centrifuged (5 min, 4 °C, 9300 129 g), and the supernatant was collected. Residual flavonoids in the precipitate were extracted 130 thrice with 100 μL methanol. All of the supernatant was combined, evaporated, and dissolved 131 in methanol for LC/MS/MS analyses. 132
Measurement of concentrations of quercetin derivatives in rat plasma by LC/MS/MS 133
Quercetin and its metabolites were quantified by liquid chromatography (using an 134 Table 1 . The concentrations of 149 quercetin, methylquercetin, Q3G-Q3G8, quercetin glucuronide, and quercetin sulfate in 150 plasma were calculated from the peak area of each MRM chromatogram and the calibration 151 curves of each standard compound. 152
The preparation of S9 homogenates from rat intestine, liver and kidney 153
Three male Wistar/ST rats (8 weeks old; Japan SLC, Shizuoka, Japan) were 154 sacrificed, and collected liver, kidney and whole the small intestine without duodenum, 155 which was from 3 cm distal of the Treitz ligament to the teriminal ileum. (3-, 7-, 4′-, and 3′-glucuronide) and one additional uncharacterized peak was obtained. The 198 three regioisomers of quercetin sulfates were also identified. We labeled 3 or 7-sulfate for the 199 first small peak because the peak was not able to be identified the sulfate position 3 or 7. We 200 showed the standard chromatograms of conjugates as Supplemental Fig.1 . 201
Concentrations of total quercetin, which was a sum of concentrations of quercetin 202 aglycone, methylquercetin, Q3G, quercetin glucuronides, and quercetin sulfates, were much 203 higher in the portal plasma than in the superior vena cava blood plasma during 30-240 min 204 time interval (Fig. 3A ). Absorptive intensities of quercetin, which were evaluated by 205 subtracting its concentrations in the superior vena cava plasma from those in the portal vein 206 plasma (porto-venous differences), increased during 30-60 min time interval, thereafter, 207 started decreasing (Fig. 3B ). The concentrations of quercetin aglycone in the superior vena 208 cava blood were very low compared to those in the portal blood, which indicates that most of 209 the aglycone absorbed into the portal blood does not recirculate into the intestine (Figs. 4A 210 and 4C). In contrast, the concentration of methylquercetin in the superior vena cava blood 211 was not significantly different from that in the portal blood ( Fig. 4B ). Concentrations of Q3G 212 in the portal blood were extremely low (below 1 μmol/L, data not shown). The sums of the 213 concentrations of each regioisomer of glucuronide and sulfate conjugates in the portal blood 214 were at similar levels ( Figs. 5A and B) . However, glucuronide levels in the superior vena 215 cava blood were much lower than in the portal blood. Porto-venous differences of 216 glucuronides were much higher than those of sulfates ( Figs. 5C and D) . Fig. 6 shows that the 217 molar percentage of aglycone in the AUC of its porto-venous differences was 52% and that of glucuronides was about 28%. Proportions of methylquercetin and sulfates were relatively low. 220 glucuronides was that of quercetin-7-O-glucuronide, followed by that of the 3′-O isomer (Fig.  225 7A). Porto-venous difference of 7-O isomer was much higher than the other three isomers 226 ( Fig. 7E) . The porto-venous differences of glucuronides were higher than glucuronide 227 concentrations in the vena cava. Portal blood concentrations of quercetin sulfates were 228 similar to those of glucuronides (Fig. 7B) . The quercetin sulfate isomer with the highest 229 concentration was 3′-O-sulfate at 30 min, however, 4′-O-sulfate levels reached the highest 230 120 min after an administration, and these changes and levels of three sulfates in the vena 231 cava blood were very similar to those in the portal blood ( Fig. 7D ). Porto-venous differences 232 of sulfate isomers were much lower than their concentrations in the vena cava blood, and the 233 porto-venous differences of glucuronides. and 3′-O-glucuronides was both more than 30%, and 3-O-and 4′-O-glucuronide were minor 246 components (Fig. 9A ). These isomer proportions were similar among tissues used. Sulfate 247 conjugation has different positional selectivity between tissues. In the small intestinal 248 enterocytes, 3′-sulfate was major metabolites, and 4′-sulfate were not detected. Liver also had 249 the high sulfation activity at 3′-OH, however, kidney had the highest activity at 7 or 3 -250 position (Fig. 9B) . The comparison between the concentrations of quercetin metabolites in blood 282 plasma of the portal vein and the superior vena cava has shed some light on the intestinal 283 metabolism of quercetin. We calculated porto-venous differences in concentrations of 284 quercetin glucuronides and sulfates, and found that these differences were much higher for 285 glucuronides compared to those for sulfates. In addition, the porto-venous differences of 286 glucuronides were higher than their concentrations in the superior vena cava blood. In 287 contrast, the porto-venous differences of sulfates were much lower than their concentrations 288 in the superior vena cava blood. These results reveal that the major site of glucuronidation is 289 the intestine, but quercetin sulfates are mainly generated in tissues other than the intestine, 290 such as the liver. It has been previously described that glucuronide conjugation was rapidly 291 processed [24, 25] and the intestine was involved in this process. We also found that the intestine has a low level of methylation activity based on the results of porto-venous 293 differences of methylquercetin, and this result is supported by a previous study [26] . 294
We evaluated not only the conjugation type, but also the regioselectivity of the 295 glucuronide and the sulfate conjugation. Five peaks were detected in the quercetin 296 glucuronide MRM chromatogram of quercetin glucuronide, which was consistent with the 297 previous study [27] . Quercetin 3-, 7-, 4′-and 3′-O-glucuronide were identified with standard 298 compounds, an unidentified peak is assumed to belong to quercetin-5-O-glucuronide. In our 299 in vivo experiment, order for positional isomer of glucuronides in portal vein blood was 7 > 3′ 300 > 3 > 4′, which did not match the order in the superior vena cava blood. The positional 301 isomer profile in the superior vena cava blood may be affected by regioselective 302 glucuronidation activities of tissues other than the intestine. UDP-glucuronosyltransferases 303 (UGT), which catalyzes quercetin glucuronidation, are composed of the UGT1 and UGT2 304 families in both human and rats. In the human isoform, UGT1A9 preferentially generates 7-305 O-glucuronide, while UGT1A1 and UGT1A8 preferentially generate 3′-O-glucuronide [28] . 306
Regioselectivity of the UGT isoform in rats has not been fully investigated, but it has been 307 reported that mRNA expression of UGT in each tissue was examined in rats [29] . Therefore, 308 the isoforms of UGT expressed was different between each tissues, and was possibly 309 affecting position selectivity. In the present study, we performed in vitro experiments using 310 S9 fractions including UGTs and SULTs in the intestinal enterocytes, liver and kidney. The 311 regioselectivities for glucuronidation were similar between tissues, which were equally 312 higher in 7 and 3′ positions than other positions, and which was consistent with previous 313 studies [28]. These results do not agree with the regioselectivities in porto-venous differences, 314 which is much higher glucuronidation at 7-position than 3'-position. We considered two 315 possibilities. The first possibility is that the 7-O-glucuronide is more acceptable to further 316 conjugation on other hydroxy groups in vivo rats. It is reported that the quercetin has conjugated at multiple hydroxyl groups, such as quercetin diglucuronide, quercetin glucuronide sulfate, and methylquercetin glucuronide sulfate [30] . Using S9 fraction 319 experiments, we did not detect these complex quercetin metabolites, which possibly be 320 associated with cell destruction. The second possible reason is that the 7-O-glucuronide is 321 rapidly removed from the blood into urine or bile. However, it has not been reported whether 322 the regioselectivity of glucuronide conjugates affect the activity of further conjugation and 323 the affinity for transporters related to excrete into urine or bile. Further studies are necessary. 324
In positional isomers of quercetin sulfates, the site of predominant conjugation was 325 3′-position at 30 min in both the portal and superior vena cava blood. However, quercetin-4′-326 sulfate was preferentially generated 120-240 min after a quercetin administration. The levels 327 of porto-venous difference were very low, but the profile was similar. These results indicate 328 that the predominant position of sulfate changes over time from 3′-OH to 4′-OH of quercetin, 329 and sulfate formation occurred in tissues other than the intestine. We determined 330 regioselective activities of quercetin sulfation by S9 protein fractions of intestinal epithelium, 331 liver and kidney, and found 3′-O-sulfation activities were relatively high in both the intestine 332 and liver, but not in kidney. We also revealed the 4′-O-sulfation activities were very low in 333 all tissues. It is difficult to explain the increase in blood levels of 4′-O-sulfate in a later phase. 334
We speculate a possibility that the accumulation of 4′-O-sulfate in the blood is associated 335 with low excretion rate into the urine or bile of this isomer, however, it is necessary for 336 further investigation. Unidentified small peak of sulfate represents either quercetin-3-O-337 sulfate or quercetin-7-O-sulfate. It has been reported that quercetin-7-O-sulfate is generated 338 by the rat liver microsome [31,32], but there have been no reports on the conjugation of 339 quercetin-3-O-sulfate in rats. Therefore, the unidentified peak in quercetin sulfate
The existence of glucuronides, sulfates, diglucuronides, and disulfides of quercetin or methylquercetin in the blood has been known from previous studies [30, 33] . We predicted 343 levels of these complex quercetin conjugates in blood plasma by subtracting total 344 concentration of quercetin derivatives detected by LC/MS/MS analyses from the value of 345 total quercetin detected using deconjugation enzymes (data not shown). Estimated levels of 346 the conjugates in the porto-venous difference were less than 20% in the present study. 347
However, it is necessary to quantify di-and tri-conjugates to evaluate the whole metabolism 348 of quercetin in the future. 349
In conclusion, our results using conscious rats demonstrated that the major site of 350 glucuronidation of quercetin is the intestinal epithelium, and that quercetin-7-O-glucuronide 351 is the major isomer generated in the intestine. We also found that the regiospecificity of 
